Shell Asset Management CO Edwards Lifesciences Corp Transaction History

Shell Asset Management CO

$2.27 Billion
Q3 2024

A detailed history of Shell Asset Management CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Shell Asset Management CO holds 44,852 shares of EW stock, worth $3.36 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

44,852

Previous 34,983 28.21%

Holding current value

$3.36 Million

Previous $3.23 Million 8.39%

% of portfolio

0.13%

Previous 0.15%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$59.7 - $93.78 $589,179 - $925,514	9,869 Added 28.21%	44,852 $2.96 Million
Q1 2024 Jul 31, 2024	SELL	$72.54 - $95.56 $340,430 - $448,463	-4,693 Reduced 11.83%	34,983 $3.23 Million
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $750,353 - $988,472	-10,344 Reduced 20.68%	39,676 $3.79 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $805,685 - $1.02 Million	-13,056 Reduced 20.7%	50,020 $3.81 Million
Q3 2023 Nov 08, 2023	SELL	$69.28 - $93.38 $85,491 - $115,230	-1,234 Reduced 1.92%	63,076 $4.37 Million
Q2 2023 Jul 28, 2023	SELL	$81.41 - $94.33 $681,890 - $790,108	-8,376 Reduced 11.52%	64,310 $6.07 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $97,280 - $110,708	1,310 Added 1.84%	72,686 $6.01 Million
Q4 2022 Feb 07, 2023	BUY	$68.3 - $87.44 $1.24 Million - $1.58 Million	18,103 Added 33.98%	71,376 $5.33 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $1.09 Million - $1.42 Million	-13,254 Reduced 19.92%	53,273 $4.4 Million
Q2 2022 Aug 09, 2022	BUY	$86.5 - $128.27 $80,531 - $119,419	931 Added 1.42%	66,527 $6.33 Million
Q1 2022 May 04, 2022	SELL	$101.96 - $128.34 $2.14 Million - $2.7 Million	-21,000 Reduced 24.25%	65,596 $7.72 Million
Q4 2021 Feb 09, 2022	BUY	$106.37 - $130.68 $877,020 - $1.08 Million	8,245 Added 10.52%	86,596 $11.2 Million
Q3 2021 Nov 04, 2021	BUY	$102.91 - $122.75 $158,069 - $188,544	1,536 Added 2.0%	78,351 $8.87 Million
Q2 2021 Aug 12, 2021	SELL	$83.84 - $104.76 $307,273 - $383,945	-3,665 Reduced 4.55%	76,815 $7.96 Million
Q1 2021 May 10, 2021	BUY	$78.68 - $90.67 $319,047 - $367,666	4,055 Added 5.31%	80,480 $6.73 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $1.09 Million - $1.39 Million	15,185 Added 24.8%	76,425 $6.97 Million
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $812,192 - $1.06 Million	-12,088 Reduced 16.48%	61,240 $4.89 Million
Q2 2020 Aug 10, 2020	BUY	$57.54 - $76.95 $2.42 Million - $3.24 Million	42,044 Added 134.39%	73,328 $5.07 Million
Q1 2020 May 11, 2020	SELL	$52.41 - $81.0 $189,514 - $292,896	-3,616 Reduced 10.36%	31,284 $5.9 Million
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $580,196 - $664,272	8,092 Added 30.19%	34,900 $8.14 Million
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $49,363 - $60,494	-802 Reduced 2.9%	26,808 $5.9 Million
Q2 2019 Aug 12, 2019	BUY	$55.74 - $64.41 $212,871 - $245,981	3,819 Added 16.05%	27,610 $5.1 Million
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $611,405 - $750,127	-13,174 Reduced 35.64%	23,791 $3.64 Million
Q3 2018 Nov 13, 2018	BUY	$45.7 - $58.03 $154,009 - $195,561	3,370 Added 10.03%	36,965 $6.44 Million
Q2 2018 Aug 10, 2018	SELL	$42.45 - $51.3 $14,645 - $17,698	-345 Reduced 1.02%	33,595 $4.89 Million
Q1 2018 May 14, 2018	BUY	$37.19 - $47.45 $9,297 - $11,862	250 Added 0.74%	33,940 $4.74 Million
Q4 2017 Feb 09, 2018	BUY	$33.79 - $39.39 $149,892 - $174,734	4,436 Added 15.16%	33,690 $3.8 Million
Q3 2017 Oct 20, 2017	BUY	$36.29 - $38.83 $1.06 Million - $1.14 Million	29,254 New	29,254 $3.2 Million
Q3 2017 Oct 18, 2017	SELL	$36.29 - $38.83 $700,977 - $750,040	-19,316 Closed	0 $0
Q2 2017 Oct 20, 2017	SELL	N/A	-20,216 Reduced 51.14%	19,316 $2.28 Million
Q1 2017 Oct 20, 2017	SELL	N/A	-9,864 Reduced 19.97%	39,532 $3.72 Million
Q4 2016 Oct 20, 2017	BUY	N/A	1,842 Added 3.87%	49,396 $4.63 Million
Q3 2016 Oct 20, 2017	BUY	N/A	47,554	47,554 $5.73 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Edwards Lifesciences Corp Transaction History